WILL SOLANA RALLY SOON?🚨 (Solana Price Prediction 2026)
1 extracted signal · 1 resolved · 0 still active
Cilinix Crypto24 May 2026, 10:51 UTC
AI-generated source summary
Solana (SOL) is currently trading within a range, with resistance noted at 88-88.50. The asset has shown some upward momentum recently, but the overall market sentiment suggests a potential downturn. Key support levels are identified at 83.50 and 81.50, with a critical support at 78. The failure to hold the 88-88.50 resistance level could lead to a retest of the 83.50 support. Further downside could target 81.50 and potentially 78 if the broader market sentiment turns negative. The current funding rates are positive, but this is not sufficient to overcome the bearish technical outlook. A break above 90 would be required to invalidate the bearish short-term outlook.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Signals in this source
More Prediction Case Files from Cilinix Crypto
BREAKDOWN UPDATE: WILL CRYPTO CRASH LOWER?🚨
DON'T MISS THIS MAJOR BULLISH SIGNAL!🔥 (Polkadot Update)
HEDERA PRICE PREDICTION FOR AUGUST! (HBAR Update)
SOLANA BREAKDOWN WARNING NOW!🚨 (SOL Update)
I AM WAITING FOR THIS ETHEREUM MOVE! (ETH Update)
CRITICAL MOMENT FOR XRP! (Breakdown Risk)
Cilinix Crypto
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.